These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19037018)

  • 1. Subtraction MR images in a multiple sclerosis multicenter clinical trial setting.
    Moraal B; Meier DS; Poppe PA; Geurts JJ; Vrenken H; Jonker WM; Knol DL; van Schijndel RA; Pouwels PJ; Pohl C; Bauer L; Sandbrink R; Guttmann CR; Barkhof F
    Radiology; 2009 Feb; 250(2):506-14. PubMed ID: 19037018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved detection of active multiple sclerosis lesions: 3D subtraction imaging.
    Moraal B; Wattjes MP; Geurts JJ; Knol DL; van Schijndel RA; Pouwels PJ; Vrenken H; Barkhof F
    Radiology; 2010 Apr; 255(1):154-63. PubMed ID: 20308453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials.
    Moraal B; van den Elskamp IJ; Knol DL; Uitdehaag BM; Geurts JJ; Vrenken H; Pouwels PJ; van Schijndel RA; Meier DS; Guttmann CR; Barkhof F
    Ann Neurol; 2010 May; 67(5):667-75. PubMed ID: 20437564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating Nonlinear Registration to Improve Subtraction Images for Lesion Detection and Quantification in Multiple Sclerosis.
    Kotari V; Salha R; Wang D; Wood E; Salvetti M; Ristori G; Tang L; Bagnato F; Ikonomidou VN
    J Neuroimaging; 2018 Jan; 28(1):70-78. PubMed ID: 29064129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
    Horsfield MA; Rocca MA; Pagani E; Storelli L; Preziosa P; Messina R; Camesasca F; Copetti M; Filippi M
    J Neuroimaging; 2016 Jul; 26(4):395-402. PubMed ID: 27019077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image registration and subtraction to detect active T(2) lesions in MS: an interobserver study.
    Tan IL; van Schijndel RA; Fazekas F; Filippi M; Freitag P; Miller DH; Yousry TA; Pouwels PJ; Adèr HJ; Barkhof F
    J Neurol; 2002 Jun; 249(6):767-73. PubMed ID: 12111312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
    Tourdias T; Roggerone S; Filippi M; Kanagaki M; Rovaris M; Miller DH; Petry KG; Brochet B; Pruvo JP; Radüe EW; Dousset V
    Radiology; 2012 Jul; 264(1):225-33. PubMed ID: 22723563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
    Janardhan V; Suri S; Bakshi R
    Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis.
    Eichinger P; Schön S; Pongratz V; Wiestler H; Zhang H; Bussas M; Hoshi MM; Kirschke J; Berthele A; Zimmer C; Hemmer B; Mühlau M; Wiestler B
    Radiology; 2019 May; 291(2):429-435. PubMed ID: 30860448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
    Granberg T; Uppman M; Hashim F; Cananau C; Nordin LE; Shams S; Berglund J; Forslin Y; Aspelin P; Fredrikson S; Kristoffersen-Wiberg M
    AJNR Am J Neuroradiol; 2016 Jun; 37(6):1023-9. PubMed ID: 26797137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmentation of subtraction images for the measurement of lesion change in multiple sclerosis.
    Duan Y; Hildenbrand PG; Sampat MP; Tate DF; Csapo I; Moraal B; Bakshi R; Barkhof F; Meier DS; Guttmann CR
    AJNR Am J Neuroradiol; 2008 Feb; 29(2):340-6. PubMed ID: 18272569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian classification of multiple sclerosis lesions in longitudinal MRI using subtraction images.
    Elliott C; Francis SJ; Arnold DL; Collins DL; Arbel T
    Med Image Comput Comput Assist Interv; 2010; 13(Pt 2):290-7. PubMed ID: 20879327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.
    Gavra MM; Voumvourakis C; Gouliamos AD; Sfagos C; Vlahos LJ
    Neuroradiology; 2004 Mar; 46(3):205-10. PubMed ID: 14985887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype.
    Roccatagliata L; Vuolo L; Bonzano L; Pichiecchio A; Mancardi GL
    Radiology; 2009 May; 251(2):503-10. PubMed ID: 19401576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b.
    Richert ND; Ostuni JL; Bash CN; Duyn JH; McFarland HF; Frank JA
    AJNR Am J Neuroradiol; 1998 Oct; 19(9):1705-13. PubMed ID: 9802494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.
    Geurts JJ; Pouwels PJ; Uitdehaag BM; Polman CH; Barkhof F; Castelijns JA
    Radiology; 2005 Jul; 236(1):254-60. PubMed ID: 15987979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of magnetic resonance imaging response to interferonbeta-1b in multiple sclerosis.
    Sormani MP; Bruzzi P; Beckmann K; Kappos L; Miller DH; Polman C; Pozzilli C; Thompson AJ; Wagner K; Filippi M
    J Neurol; 2005 Dec; 252(12):1455-8. PubMed ID: 16021360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subject movement during multislice interleaved MR acquisitions: prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
    Gedamu EL; Gedamu A
    J Magn Reson Imaging; 2012 Aug; 36(2):332-43. PubMed ID: 22581754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.
    Grimaud J; Lai M; Thorpe J; Adeleine P; Wang L; Barker GJ; Plummer DL; Tofts PS; McDonald WI; Miller DH
    Magn Reson Imaging; 1996; 14(5):495-505. PubMed ID: 8843362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI: role in optimising treatment.
    Traboulsee A
    J Neurol; 2004 Sep; 251 Suppl 5():v36-v41. PubMed ID: 15549354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.